Our aim was to investigate AFP, PIVKA-II and GPC-3 diagnostic accuracy for the detection and the prediction of HCC development in patients with cirrhosis of viral etiology under surveillance. The gene discussed is AFP; the disease is hepatocellular carcinoma.